Brain scan study on glutamate and ketamine in healthy adults
Treatments studied
This study uses a special brain scan (MRI) to understand how the brain chemical glutamate works in healthy people. You may be asked to take either an experimental drug or a placebo to see how it affects your brain chemistry.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You are generally healthy and have no major medical conditions, such as uncontrolled high or low blood pressure, kidney problems, or heart disease.
- You do not have a current or past psychiatric illness (like depression, anxiety, or addiction) other than nicotine dependence.
- You are not taking any psychiatric medications (like antidepressants, mood stabilizers, or stimulants).
- You have no history of suicide attempts or recent suicidal thoughts with a plan.
- You must not be pregnant, breastfeeding, and you must agree to use reliable birth control if you could become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a single dose of ketamine can change brain wave patterns (called gamma oscillations) in people with treatment-resistant depression. Researchers want to see if these brain waves can predict who will feel better after treatment.
This trial tests whether a single dose of ketamine can quickly improve depression by studying brain chemical changes using MRI. It's for people with treatment-resistant depression who haven't used ketamine before.
This early-stage study looks at how parts of brain cells respond to ketamine in people with depression who have not improved with usual antidepressants. It may help researchers find why ketamine works for some people and not others, and who might benefit.
This trial is for people with severe major depression who may benefit from a single dose of ketamine. Researchers want to see if certain biomarkers in your blood or brain can predict how well ketamine works for you.
This trial studies how ketamine affects brain circuits in people with depression compared to healthy volunteers. It involves a single infusion of ketamine and brain scans before and after.
This study tests how ketamine affects brain chemicals linked to suicidal thoughts in people with depression. You will receive ketamine and have brain scans (PET and MRI) to see if it changes activity in opioid receptors.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.